Home
About
Overview
Sharing Data
ORCID
Help
History (12)
ON-pathway dysfunction in a patient with acquired unilateral night blindness.
Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Should angioplasty and stenting be performed before CAGB in patients with asymptomatic carotid stenosis?
Stroke patient outcomes in US hospitals before the start of the Joint Commission Primary Stroke Center certification program.
The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer.
The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. Neurology. 2009 Dec 15; 73(24):2058-9.
View in:
PubMed
subject areas
Brain Ischemia
Coronary Artery Bypass
Cytoprotection
Enzyme Inhibitors
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Preoperative Care
Stroke
authors with profiles
Larry Goldstein